Cargando…
A 4-trifluoromethyl analogue of celecoxib inhibits arthritis by suppressing innate immune cell activation
INTRODUCTION: Celecoxib, a highly specific cyclooxygenase-2 (COX-2) inhibitor has been reported to have COX-2-independent immunomodulatory effects. However, celecoxib itself has only mild suppressive effects on arthritis. Recently, we reported that a 4-trifluoromethyl analogue of celecoxib (TFM-C) w...
Autores principales: | Chiba, Asako, Mizuno, Miho, Tomi, Chiharu, Tajima, Ryohsuke, Alloza, Iraide, di Penta, Alessandra, Yamamura, Takashi, Vandenbroeck, Koen, Miyake, Sachiko |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3392797/ https://www.ncbi.nlm.nih.gov/pubmed/22251404 http://dx.doi.org/10.1186/ar3683 |
Ejemplares similares
-
A Trifluoromethyl Analogue of Celecoxib Exerts Beneficial Effects in Neuroinflammation
por: Di Penta, Alessandra, et al.
Publicado: (2013) -
Pharmacological Targeting of the ER-Resident Chaperones GRP94 or Cyclophilin B Induces Secretion of IL-22 Binding Protein Isoform-1 (IL-22BPi1)
por: Gómez-Fernández, Paloma, et al.
Publicado: (2019) -
Interactome of the Autoimmune Risk Protein ANKRD55
por: Ugidos, Nerea, et al.
Publicado: (2019) -
The dual role of short fatty acid chains in the pathogenesis of autoimmune disease models
por: Mizuno, Miho, et al.
Publicado: (2017) -
Characterization of Carotid Smooth Muscle Cells during Phenotypic Transition
por: Goikuria, Haize, et al.
Publicado: (2018)